The rapidity with which molecular sequence data are gathered continues to grow. The result is that, for many workers, it is increasingly difficult to keep abreast of the current state of play of molecular cloning, even for those genes that encode proteins of special interest The clear success of the various worldwide genome projects has made this even more apparent, and by the end of 1996 the complete determination of the nucleotide sequences of the genomes of two eukaryotes, Saccharomyces cerevisiae and Caenorhabditis elegans, will have either been completed or will be nearing completion. This article is an attempt to provide, in an easily accessible format, a compilation of genes and cDNAs that have been sequenced and deposited in GenBank that encode transferase enzymes involved hi eukaryotic glycoprotein or glycolipid biosynthesis. The full sequence information can be easily retrieved from a databank, e.g. GenBank, using the relevant accession numbers).
Introduction
The rate of acquisition of nucleotide data continues to increase. Even with the availability of on-line databases such as GenBank, the EMBL database and others, it is often hard to maintain awareness of the current state of a given field. Simple search strings are frequently inefficient at complete retrieval of the required data; for example, a search for 'glycosyltr*' in GenBank, where '*' is a wild card character, results in very few retrieved entries, and more complex strategies result in a vast increase in the amounts of undesired data being obtained. This is as true of enzymes involved in the construction and processing of eukaryotic complex carbohydrate moieties as it is for any other area.
As a first approach to maintaining a current awareness survey of the progress in molecular cloning of glycosyltransferase genes and cDNAs, we have performed an extensive search of GenBank and the yeast genome sequence database. The present article is restricted to sequences from eukaryotes with a submission date of 1994 or earlier. The search has also been heavily restricted to include only those enzymes involved in processing glycoprotein and glycolipid carbohydrate moieties, and therefore excludes such areas as glucosyltransferases involved in starch and sucrose synthesis, and the modifications of other metabolic products, e.g. flavenoid glucosylation.
Conversely, in a number of cases there is evidence to suggest that a number of transferase activities are present on the cytoplasmic face of the secretory compartments. This orientation is particularly common for those enzymes involved in the synthesis of glycolipid glycans, e.g. the galactosyltransferase catalysing the formation of galactosylceramide, and several steps in the synthesis of glycosylphosphatidylinositol (GPI) lipids (126, 127) . The basic biosynthetic pathways for glycolipids of the sphingomyelin/ganglioside family, the GPI lipids and the N-and O-linked protein processing pathways have all been extensively reviewed (125, (128) (129) (130) (131) 137) .
The vast majority of glycosyltransferase enzymes working to elaborate glycan chains are of the type 2 transmembrane structure, i.e. containing a lumenally oriented C-terminus, the catalytic domain, a single membrane-spanning region and a cytoplasmic N-terminus (60) (61) (62) 67) , as shown in Figure 1A . The membrane-spanning region can confer important localization determinants, as elegantly demonstrated for sialyltransferase and galactosyltransferase (132, 133) . During early studies, many glycosyltransferases were believed to be soluble as any attempt to disrupt the cell to purify them resulted in the production of a clipped form of the enzyme, constituting the lumenal and enzymatically active C-terminal domain, cleaved between the catalytic domain and the transmembrane-spanning domain within the stalk region ( Figure 1A ). Molecular cloning studies served to explain the somewhat paradoxical observations that soluble enzymes without any discernible mechanism for retention within the secretory pathway could be shown to be tightly localized to specific subcompartments, as demonstrated by numerous ultrastructural studies. These observations also demonstrate that the C-terminal domain contains all the necessary information that is required for catalysis. As few of the enzymes involved in elaboration of ceramide or the GPI-lipids have been cloned, the precise topology of this group of proteins within the microsomal membranes remains to be fully determined.
Most of the lumenal glycosyltransferases are themselves glycoproteins. There is minimal homology between transferases beyond the basic domain structure (134, 141) . Within families of transferases there is considerable homology and a large number of members of, for example, the fucosyltransferase family, have been cloned by homology-based approaches, e.g. low-stringency screens or polymerase chain reaction (PCR) methods (see Table I for some examples). This latter family is particularly interesting as there is an extensive region, the Lewis X (LeX) locus, on human chromosome 19, that contains several similar al,3/4-fucosyltransferases that are very closely related to each other at the nucleotide level, but have subtle differences in both precise specificity and tissue-specific expression (see below). Like most other eukaryotic genes, the glycosyltransferase genes are split by the presence of introns, and transcription is often initiated at more than one site, sometimes in a tissue-specific manner (see Figure IB) . In yeast, the presence of introns is characteristically low. Alternative exon usage can also lead to message heterogeneity, and in some cases even to different sized protein products. This topic has been thoroughly reviewed recently (121, 141) .
What follows is the result of our database searches for the period up to the end of 1994. The retrieved data are summarized with the accession numbers, the citation(s) that are associated with the sequence entries and the EC numbers for the activities, where available. Individual classes of glycosyltransferases are discussed briefly below.
Results and discussion
There were over 130 entries with distinct accession numbers in the GenBank database at the end of 1994. The earliest entries obtained were four galactosyltransferases in 1985, and since then a total of -130 distinct glycosyltransferases have been cloned (see Figure 2 ). However, in many cases the homologue from several species has been studied, so that the total number is an overestimate of the repertoire now available in the database, and sequence data for a number of important activities remain completely lacking. The database information is summarized in Table I . It is possible that a small number of entries have been missed, but these are unlikely to alter our overall picture of the current state of molecular cloning of this group of eukaryotic enzymes.
Simple inspection of the table reveals two major points worthy of comment. Firstly, and most obviously, several enzymes are more heavily studied than others. Particularly well studied are the galactosyltransferases, the fucosyltransferases and the sialyltransferases. Clearly, the interest in these activities stems from the fact that they are responsible for terminal elaborations, and are therefore of more immediate biological relevance. The galactosyltransferases were, in fact, the first group of transferases to come under close scrutiny and, in the 4 years spanning 1986 to 1989, galactosyltransferase sequences accounted for -70% of the then 23 entries in the database. Since 1989, the situation has become significantly more diverse, certainly in part reflecting interest in such structures as sialyl Lewis X (SLeX), involved in a number of cell adhesion events (122) . Secondly, the pace at which glycosyltransferases are being cloned is increasing. Inspection of Figure 2 suggests an almost exponential increase in the total number of entries in the database with time. If this is to continue, then -35-40 new sequences will become available by the end of 1995. It is interesting to note that the data from various genome sequence projects have not been fully released to the databases as yet and, rather unexpectedly, only -15% of the sequences retrieved have been obtained by this 'brute force' route. The impact that yeast sequencing has had on the number of mannosyltransferase sequences has been quite dramatic (but obviously, from the nature of yeast glycosylation, the impact on e.g. galactosyltransferase cloning is not going to be significant), and therefore the database can be expected to expand greatly when data are gathered from organisms with wider repertoires of glycan elaboration, e.g. Caenorhabditis elegans. Importantly, these largescale studies will shed light on the genomic organization of glycosyltransferase genes, particularly poignant for the fucosyltransferase family, members of which are clustered (see below), and provide greater insight into the evolution of these proteins, their transcriptional control and ultimately the function that the glycans they synthesize have in a wider biological context.
We have refrained from providing phylogenetic reconstructions of the various gene families as the data are heavily imbedded within flanking sequences and introns, and would be too numerous for the present article. We hope that the provision of accession numbers and citations will allow interested workers to perform these studies using suitable software routines like PileUp from the GCG package (135) and PAUP (136) . We have also completely avoided discussing the cloning strategies employed in obtaining these data. Whilst such information can be of considerable interest to those in the field, it is out of place here and the reader is referred to the excellent recent article by Table I . Listing of eukaryotic glycosyltransferases that act on glycoproteins and glycolipids. For clarity, the enzyme names have been truncated. Systematic names, with the corresponding EC numbers, are given in Table II . In many cases, the gene or cDNA sequence has been obtained by homology (probing or PCR) or shotgun sequences, and the precise specificity of the encoded enzyme has not been determined. In these cases, an EC number is not given. NK, not known (in cases where the specificity of the transferase has not been defined •See the list of abbreviations for this and others used in the table.
Schachter which covers this area in quite some depth (120). The remaining discussion will focus on particular glycosyltransferase classes/families.
Sialyltransferases
There are sequences for three major types of sialytransferase in the database: those forming a2,3, oc2,6 and a2,8 linkages. The donor sugar is linked to CMP. The examples of the a2,3-and (x2,6-forming transferees are restricted to those acting on N-and O-linked glycans of glycoproteins, whilst the two o2,8-specific transferases act on glycolipids and form polysialic acids. There is considerable evidence for tissue-specific expression of some of the enzymes, together with the use of alternative splicing, e.g. M83142 etcetera and M73985. In the latter case, there is also evidence for the use of alternate promoter elements for the initiation of transcription in a tissue-specific manner.
Examples of sialyltransferases with defined high levels of specificity include X74946, for 0-glycan sialylation, D28941 for synthesis of SLeX, and X77922 for production of GD2. A further curiosity is X54363, which was isolated in an attempt to clone the CD75 antigen from B cells. This clone turned out to encode a sialyltransferase responsible for synthesis of the CD75 antibody epitope (26) .
Fucosyltransferases
The fucosyltransferases are perhaps the most complex group at the genomic level. They transfer fucose from UDP in al-2, al-3, al-4 and al-6 linkage. The latter two specificities can apparently be encoded by the same polypeptide. In Homo sapiens, there are a number of these transferase genes present as part of a cluster, the LeX locus, on chromosome 19. At least two of the genes in this locus are positioned very close to each 
In formal notation the name of an enzyme is given as substrate 1 (donor): substrate 2 (acceptor) followed by the activity. All the glycosyltransferases considered here have EC designations beginning 2.4, designating them as glycosyltransferases. EC 2.4.1 are hexosyltransferases, and EC 2.4.99 are nonhexosyl-nonpentosyl-transferases, e.g. the sialyltransferases (121) . As these are highly cumbersome, most enzymes are commonly known by trivial names, and this is equally the case for glycosyltransferases. This table allows the full name to be correlated with the accession number and other information given in Table I EC number Systematic enzyme name The period 1984-1994 is covered. According to this search, the first glycosyltransferases to be cloned, sequenced and submitted to GenBank were four galactosyltransferases, in 1986. Dates are taken from the date of publication of the sequence in a refereed journal and therefore are not necessarily the same as the submission date (a few sequences unpublished at the time of writing are included by submission date). A score of one per publication has been used as a more reliable index of activity than scoring accession numbers, as several reports have generated large numbers of sequence submissions which would artificially inflate the apparent rate of progress.
other; fucosyltransferase IV (S52987) and fucosyltransferase III (X53578) are within 13 kb of each other (37) , and several more genes are probably located in this region, e.g. M81485.
Interest in this particular area has arisen because the E-selectin cell adhesion molecule requires SLeX to be present on its ligand for recognition (122) , although other structures also appear to be functional, and therefore most of the fucosyltransferases have been examined for their potential to form SLeX and LeX in different in vivo and in vitro assays. Results are occasionally contradictory, with subtle differences being displayed between the various a 1,3 fucosyltransferases and the cell type within which they are expressed. The enzyme responsible for addition of core fucose (a 1-6 linked) has not been cloned. A final enzyme of note within this group is the a 1,2 fucosyltransferase responsible for formation of the blood group H structure (M35531).
Galactosyltransferases
The galactosyltransferases are an ever popular group of enzymes, catalysing the addition of galactose from UDP-gal in al-3, (31-3, pl-4 and a variety of other linkages. They were the first group to be studied at the molecular genetic level, new sequences are still being generated, and they represent the largest single group in the database, with 37 entries. Many of these are redundant. In common with the sialyltransferases, there is substantial evidence for developmental regulation and alternative exon use with complex control of transcriptional initiation (see Figure 1 ). Unique for this class is the observation of pseudogenes in the human genome, related to the al,3-type transferase. This is most probably involved in the interesting evolutionary phenomenon of the a-gal/anti-a-gal system, whereby Old World higher primates, including humans, have high levels of antibodies recognizing al,3-linked terminal galactose, but do not synthesize the linkage, whereas in most other mammals the linkage is present and the antibody specificity is absent (57) . Two sequences of glycolipid-specific enzymes from rat brain are in the database, and a galactofuranose transferase from Leisnmania donovani has been reported. Only one galactosyltransferase sequence has been obtained from the genome sequencing programme to date (Z29095, from C.elegans).
N-Acetylglucosaminyltransferases
This group of enzymes add GlcNAc from UDP-GlcNAc in a number of linkages; most common are pl-4 (the core) and pi-2 (outer arm), but other linkages, e.g. (31-6, are also common amongst the more elaborate jV-glycans and O-glycans. The enzyme responsible for the initiation of synthesis of the lipid-linked N-glycan precursor has been cloned from six different organisms. This enzyme is responsible for the sensitivity of N-glycan biosynthesis to tunicamycin, and is of interest as a key point in N-glycan biogenesis. Four of the N-acetylglucosaminyltransferases have been cloned by genome sequence projects. Owing to the importance of these enzymes in some of the later control points of N-glycan elaboration, this area should be active for some time, and one of these (GlcNAc transferase I) has been the subject of a recent gene knockout study unequivocally demonstrating the importance of glycan processing to the multicellular state (142) .
N-Acetylgalactosaminyltransferases
These enzymes include two alleles of the blood group A: a ganglioside-specific transferase, and the activity responsible for the initiation of O-glycan chains on serine and threonine residues of polypeptides.
Mannosyltransferases
The vast majority of mannosyltransferases use GDP-man as a donor, but in the synthesis of the lipid-linked N-glycan precursor several enzymes use Dol-P-man as the mannosyl source (which is itself formed via GDP-man). Mannose can be linked in al-2, al-3, al-4 and al-6, and is also found in ^-linkage (1) (2) (3) (4) in the core region of N-glycans. The majority of mannosyltransferases have been cloned from the yeast Saccharomyces cerevisiae, including the mannose O-link initiating activity.
Glucosyltransferases
Only two of these enzymes have been cloned: those responsible for synthesis of Dol-P-Glc and for addition of glucose to the lipid-linked precursor of A/-glycan biosynthesis.
Concluding remarks
Substantial progress has been made in the molecular biology of the glycosyltransferases since the first galactosyltransferase was cloned in 1986. As a group, these enzymes are becoming of increasing interest to workers outside of the immediate glycobiology field as tools for the study of intracellular compartmentalization, retention and protein processing. It is clear from the studies on several of the enzymes, e.g. the galactosyltransferases and sialyltransferase, that control of their transcription and tissue-specific expression is an important and interesting area, which will undoubtedly contribute to unravelling many of the roles that specific carbohydrate structures play in embryogenesis, cell adhesion and immunity. Particularly important will be an understanding of the developmental control of transcription and the mechanisms by which certain enzymes are retained within subcompartments of the secretory pathway. It is intended that this database will be updated at least annually, and posted onto the World Wide Web within the near future. It is also hoped that the scope of the database can be expanded to include more information on each entry, and to include glycosylating activities of a more varied nature than those presented here.
Methods

Data retrieval
As sequence entries and flat files are now exchanged on a daily basis between all the major nucleotide databases (i.e. NDBJ, EMBL and GenBank), it is only necessary to search one of them as the data submitted to all others are, in the jargon, 'mirrored'. A second search was also performed on the S.cerevisiae genome sequence database using a download of the archive from the site at 'http://genome-www.stanford.edu'. The current database searches were performed in early 1995, and only entries submitted on or before 31 December 1994 are tabulated here.
Initially, GenBank was searched (address 'gophen//ftp.bio.indiana. edu:7(V 77/.indices/genbank?') via the World Wide Web (W3) using the Netscape browser (Vl.lb) (available by ftp or other protocol from Netscape Industries Inc.) via an Internet connection with the following keywords: glycosyltr*, mannosyltr*, glucosyltr*, galactosyltr*, sialyltr*, glucuronyltr*, N-acetylglucosaminyltr*, N-acetylhexosaminyl*, N-acetylgalactosaminyl*, UDP-GalNAc, GDP-Man and GalNAc. Approximately 1000 entries were retrieved, of which -150 were from eukaryotic sources. Interestingly, glycosyltr* produced <20 hits, and therefore is not a suitable search string. The W3 retrieval provided a rapid method to obtain accession numbers and to screen out undesired files without the need for a full file download as a brief title is also provided as part of the hypertext file name. The yeast genome was searched using glycosyltr*, mannosyltr*, glucosyltr*, galactosyltr*, sialyltr*, glucuronyltr* and transferase. A number of additional entries were also obtained by scanning the literature. Hat files were then retrieved from GenBank using an email program 'Eudora' (Qualcomm Inc.) to NetServ@ebi.ac.uk using the command 'GET NUC:' followed by the accession number (no spaces). The accumulated email messages were then converted to a single text file by extraction of the text string in the 'In' box of the Eudora mailer package, and the individual entries were then examined to abstract the relevant information as presented in Table I and Figure 2 .
